TACSTD2 and colorectal carcinoma: In CRC, as compared to TACSTD2-high tumors, TACSTD2-low tumors were enriched in MSI-high (4.8% vs 10.6%) and TMB-high (8% vs 13.6%), respectively (Figure 3B, 3C).